Nokia Looks For Two Bites Of The Apple
Nokia today unveiled plans to release an iPhone-style touchscreen phone next year as part of a strategy for tackling what it described as ’tough competition’ from new players in the handset mark...
Read Full Article
Bush Says Economy Is Poised To Rebound
President Bush urged Congress to resist Democrats? efforts to pass a second economic stimulus package, asking lawmakers to give his own package ?a chance to kick in.?...
Read Full Article
Taiwanese Pay HSBC £700m To Rescue Rebar Bank
An HSBC subsidiary will receive $1.5 billion ($£734.4 million) in assistance from the Taiwanese Government to rescue a failed bank on the island....
Read Full Article
Stephen Colvin, 64, Inventive Heart Surgeon, Is Dead
Dr. Colvin promoted the now widespread use of a pioneering procedure for repairing a leaky heart valve, and also performed heart surgery on children all over the world....
Read Full Article
Voters May Put Hillary Clinton In Position To Halt Barack Obama
Even as Democrats fret over the damage that the battle for the party’s presidential nomination has already done to their chances of regaining the White House, Hillary Clinton’s campaign ...
Read Full Article

Biopharma News



Jazz Lowers Offering Price

The biopharmaceutical company raised $108 million in an initial public offering that priced below a reduced forecast range.
Read Full Article

External News for: biopharma

The Brualdi Law Firm, PC Announces Class Action Lawsuit Against Hemispherx ... - CNNMoney.com (press release)

The Brualdi Law Firm, PC Announces Class Action Lawsuit Against Hemispherx ...CNNMoney.com (press release)... of purchasers of Hemispherx Biopharma, Inc. ("Hemispherx" or the "Company") (AMEX:HEB) stock during the period between February 18, 2009 and October 30, ...and more »

The Brualdi Law Firm, PC Announces Class Action Lawsuit Against Hemispherx ... - CNNMoney.com (press release)

The Brualdi Law Firm, PC Announces Class Action Lawsuit Against Hemispherx ...CNNMoney.com (press release)... of purchasers of Hemispherx Biopharma, Inc. ("Hemispherx" or the "Company") (AMEX:HEB) stock during the period between February 18, 2009 and October 30, ...and more »

Bristol-Myers Squibb Announces Split-Off Of Mead Johnson - Wall Street Journal

The Money TimesBristol-Myers Squibb Announces Split-Off Of Mead JohnsonWall Street Journal"By executing our healthcare divestment strategy, we have sharpened our BioPharma focus, improved the overall financial strength of the company and ...B-MS to be pure biopharma after Mead Johnson split-offPharma TimesBristol-Myers shares jump on news of Mead Johnson splitMarketWatchBristol Says Buh-Bye to Formula for Stability, Hello to BuybackThe IN VIVO Blog (blog)Bloomberg -FiercePharma -WELT ONLINEall 405 news articles »

The Brualdi Law Firm, PC Announces Class Action Lawsuit Against Hemispherx ... - CNNMoney.com (press release)

The Brualdi Law Firm, PC Announces Class Action Lawsuit Against Hemispherx ...CNNMoney.com (press release)... of purchasers of Hemispherx Biopharma, Inc. ("Hemispherx" or the "Company") (AMEX:HEB) stock during the period between February 18, 2009 and October 30, ...and more »

Bristol-Myers Squibb Announces Split-Off Of Mead Johnson - Wall Street Journal

The Money TimesBristol-Myers Squibb Announces Split-Off Of Mead JohnsonWall Street Journal"By executing our healthcare divestment strategy, we have sharpened our BioPharma focus, improved the overall financial strength of the company and ...B-MS to be pure biopharma after Mead Johnson split-offPharma TimesBristol-Myers shares jump on news of Mead Johnson splitMarketWatchBristol Says Buh-Bye to Formula for Stability, Hello to BuybackThe IN VIVO Blog (blog)Bloomberg -FiercePharma -WELT ONLINEall 405 news articles »

AVI BioPharma, Inc. to Present at Transformational Medical Technologies ... - CNNMoney.com (press release)

AVI BioPharma, Inc. to Present at Transformational Medical Technologies ...CNNMoney.com (press release)AVI BioPharma is focused on the discovery and development of RNA-based drugs utilizing proprietary derivatives of its antisense chemistry ...and more »

 
i8news.com